indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

IASST Guwahati scientists innovate photocatalyst to degrade broad-spectrum antibiotics

IMT News Desk

The innovation will lead to less hazardous chemicals and reduce health and environmental concerns associated with antibiotic contamination 

Scientists have developed an efficient photocatalyst that can degrade sulfamethoxazole, a broad-spectrum antibiotic to less hazardous chemicals and reduce health and environmental concerns associated with antibiotic contamination. 

Antibiotic contamination has several adverse effects, including antibiotic resistance, ecological impact, human health concerns, etc. Hence, there is a need to find ways to mitigate this environmental issue.

A team of scientists from the Institute of Advanced Study in Science and Technology (IASST), Guwahati, an autonomous institute of the Department of Science and Technology have synthesised copper zinc tin sulfide Cu2ZnSnS4 (CZTS) nanoparticles (NPs) and copper zinc tin sulfide -tungsten disulfide CZTS-WS2 composite.

The team led by Prof Devasish Chowdhury utilised a hydrothermal reaction of zinc chloride, copper chloride, tin chloride and tungsten disulfide forming a composite that is an efficient photocatalyst in degrading sulfamethoxazole, an antibiotic.

Broad-spectrum antibiotics like sulfamethoxazole (SMX) have long been used to treat human illnesses like urinary and respiratory tract infections. However, more than 54 per cent of SMX was released into the environment along with the faeces and urine of the patients.

“CZTS and its nanocomposites are a multifunctional quaternary semiconductor nanomaterial made up of earth-abundant, inexpensive, and non-toxic components possessing remarkable photostability making it extremely valuable in light-harvesting and photocatalyst applications,” said Prof Chowdhury.

The team consisting of Nur Jalal Mondal, Rahul Sonkar, Mridusmita Barman and Dr Mritunjoy Prasad Ghosh, established that the CZTS-WS2 composite exhibits good photocatalytic activity for the breakdown of sulfamethoxazole.

The developed catalyst could be recovered and used repeatedly without losing its effectiveness, which is very important from an economic point of view.

PIB

Recommended

Regeneron Secures 23andMe in $256 Million Bankruptcy Auction

Vaidya Smita Naram bags Lifetime Achievement Award at 67th International Global Ayurveda Conference

Venus Remedies joins United Nations Global Compact

SBI Securities collaborates with Sightsavers India

DavaIndia launches first multilingual pharmacy app in Varanasi

Hospital Superbug Turns Medical Plastics into a Food Source, Study Reveals

Wadi Surgicals unveils accelerator-free nitrile gloves under its flagship brand Enliva

Massive Turnover, Growing FDI: India’s Pharma Sector at a Crossroads

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions